<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate the prevalence of antineutrophil cytoplasmic antibodies (<z:chebi fb="0" ids="34507">ANCA</z:chebi>) and rheumatic manifestations associated with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">haematological malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Two groups of patients were prospectively studied (group I: 60 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> and group II: 140 patients with lymphoid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>) for clinical 'immune' manifestations and <z:chebi fb="0" ids="34507">ANCA</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: In the myelodysplastic group, six patients had <z:chebi fb="0" ids="34507">ANCA</z:chebi>-negative systemic medium-size <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, one had systemic <z:hpo ids='HP_0002633'>vasculitis</z:hpo> with cytoplasmic <z:chebi fb="0" ids="34507">ANCA</z:chebi>, one <z:e sem="disease" ids="C0032453" disease_type="Disease or Syndrome" abbrv="">relapsing polychondritis</z:e>, one giant cell <z:hpo ids='HP_0012089'>arteritis</z:hpo>, one <z:e sem="disease" ids="C0032533" disease_type="Disease or Syndrome" abbrv="pmr">polymyalgia rheumatica</z:e>, one <z:e sem="disease" ids="C0162323" disease_type="Disease or Syndrome" abbrv="">polyarthritis</z:e> and two <z:hpo ids='HP_0100537'>fasciitis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In group II, two patients had <z:chebi fb="0" ids="34507">ANCA</z:chebi>-negative systemic <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, two had leucocytoclastic <z:hpo ids='HP_0002633'>vasculitis</z:hpo> associated with <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculosis</z:e>, two had <z:e sem="disease" ids="C0162323" disease_type="Disease or Syndrome" abbrv="">polyarthritis</z:e>, one <z:e sem="disease" ids="C0032533" disease_type="Disease or Syndrome" abbrv="pmr">polymyalgia rheumatica</z:e> and one giant cell <z:hpo ids='HP_0012089'>arteritis</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Six sera were <z:chebi fb="0" ids="34507">ANCA</z:chebi>-positive with perinuclear pattern in four cases, atypical pattern in one and cytoplasmic pattern in one </plain></SENT>
<SENT sid="5" pm="."><plain>Two sera had anti-myeloperoxidase (MPO) specificity, and others had no known specificity; none had anti-proteinase 3 (PR3) specificity </plain></SENT>
<SENT sid="6" pm="."><plain>Global prevalence of <z:chebi fb="0" ids="34507">ANCA</z:chebi> in our cohort was 3%, similar to the French general population </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="C0031036" disease_type="Disease or Syndrome" abbrv="">Polyarteritis nodosa</z:e>-type systemic <z:hpo ids='HP_0002633'>vasculitis</z:hpo> and <z:e sem="disease" ids="C0032533" disease_type="Disease or Syndrome" abbrv="pmr">polymyalgia rheumatica</z:e> were the most frequent findings (18%) in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> and particularly in <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_501'>myelomonocytic leukaemia</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="0" ids="34507">ANCA</z:chebi> were not helpful for the diagnosis of <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0002633'>Vasculitis</z:hpo> associated with <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, in particular <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculosis</z:e>, must be ruled out </plain></SENT>
</text></document>